肾癌并发静脉血栓患者51例回顾性分析.pdfVIP

CHINESECOMMUNITY DOCTORS 论著·临床论坛 肾癌并发静脉血栓患者51例回顾性分析 1 2 3 1 1 1 张伟 付强 姜涛 李治钢 张博 鞠长亮 132022吉化集团公司总医院(二院)泌尿外科1 132011吉化集团公司总医院(一院)胸泌外科2 116100大连市友谊医院泌尿外科3 doi:10.3969/j.issn.1007-614x.2015.11.29 摘 要 目的：探讨不同临床特征的肾癌患者并发静脉血栓比例，为肾癌并发静脉血栓的风险评估提供临床依据。方 法：收治肾癌并发静脉血栓患者51例，分别记录不同年龄、性别、分期、病理类型、ECOG评分阶段中发生静脉血 栓患者数量及实验室检查指标在伴有静脉血栓者和无静脉血栓者的分布情况，进行统计学分析。结果：①患者年龄与 静脉血栓形成概率呈正相关(P=0.004)，当年龄≥60.2岁患者并发静脉血栓风险显著增加(P=0.005)。②ECOG评分≤2 分者静脉血栓发生率明显高于ECOG评分＞2分者，差异具有统计学意义(P=0.001)。③发生静脉血栓者纤维蛋白原水 平明显高于无静脉血栓者，差异具有统计学意义(P=0.006)。结论：年龄≥60.2岁、ECOG评分≤2分、纤维蛋白原水 平升高是初治肾透明细胞癌患者并发静脉血栓的高危因素。 关键词 肾透明细胞癌；静脉血栓；年龄；ECOG评分；纤维蛋白原 Aretrospectiveanalysisofrenalcellcarcinomapatientswithvenousthrombosisin51cases ZhangWei,FuQiang,JiangTao,LiZhigang,ZhangBo,JuChangliang1 2 3 1 1 1 DepartmentofUrology,GeneralHospitalofJilinChemicalIndustryCorporation(theSecondHospital) 1320221 ChestandUrinarySurgery,GeneralHospitalofJilinChemicalIndustryCorporation(theFirstHospital) 1320112 DepartmentofUrology,theFriendshipHospital,DalianCity 1161003 Abstract Objective:Toinvestigatetheproportionofcombinedwithvenousthrombosisinpatientswithrenalcellcarcinomawith differentclinicalcharacteristics,andtoprovidetheclinicalbasisfortheriskassessmentofrenalcellcarcinomapatientswith venousthrombosis.Methods:51renalcellcarcinomapatientswithvenousthrombosiswereselected.Werespectivelyrecordedthe numberofpatientswithvenousthrombosisindifferentage,gender,pathologicaltype,stage,ECOGscoreanddistributionsituation ofpatientswithorwithoutvenousthrombosisinindexoflaboratoryexamination,wemadeastatisticalanalysis.Results:①Theage ofpatientswaspositivelyrelatedtotheprobabilityofformingvenousthromboembolism(P=0.004),whenmorethan60.2yearsold, theriskofpatientswithvenousthrombosiswassignificantlyincreased(P=0.00